Bronchoalveolar Lavage as a Diagnostic Tool in an Atypical Pulmonary Langerhans Cell Histiocytosis.
Ovidiu Fira-MladinescuNoemi SuppiniGheorghe Emilian OlteanuCorneluta Fira-MladinescuDaniel TrailaPublished in: Diagnostics (Basel, Switzerland) (2022)
Pulmonary Langerhans cell histiocytosis (PLCH) is an uncommon diffuse cystic lung disease that occurs almost exclusively in young adult smokers. High-resolution computed tomography of the chest allows a confident diagnosis of PLCH in typical presentation, when nodules, cavitating nodules, and cysts coexist and show a predominance for the upper and middle lung. Atypical presentations require histology for diagnosis. Histologic diagnosis rests on the demonstration of increased numbers of Langerhans cells and/or specific histological changes. PLCH is one of the few diseases in which bronchoalveolar lavage (BAL) has a high diagnostic value and can in some circumstances replace lung biopsy. We present a case of PLCH in an elderly non-smoker. Chest imaging revealed the presence of advanced interstitial lung disease with a fibrocystic pattern. BAL cellular analyses disclosed a macrophage pattern with CD1a phenotype that strongly supports the PLCH diagnosis, even in the setting of atypical clinical presentation and a lack of smoking exposure. PLCH is extremely rare in non-smokers and could represent a distinct phenotype.
Keyphrases
- high resolution
- interstitial lung disease
- computed tomography
- single cell
- smoking cessation
- systemic sclerosis
- pulmonary hypertension
- young adults
- cell therapy
- rheumatoid arthritis
- magnetic resonance imaging
- induced apoptosis
- adipose tissue
- mesenchymal stem cells
- mass spectrometry
- middle aged
- endoplasmic reticulum stress
- high speed
- community dwelling
- liquid chromatography